speb/financial-data huggingface dataset:
MEDX.SW balance_sheet (annual, 2024-12-31) — Other Payable: 3100000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Other Payable: 3100000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Other Properties: 42800000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Other Properties: 42800000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Other Receivables: 3000000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3000000.00
MEDX.SW income_statement (annual, 2024-12-31) — Other Special Charges: -800000.00
MEDX.SW income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Payables: 74300000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Payables: 74300000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1900000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1900000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Prepaid Assets: 7800000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 7800000.00
MEDX.SW income_statement (annual, 2024-12-31) — Pretax Income: -6300000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Properties: 0.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MEDX.SW cash_flow (annual, 2024-12-31) — Purchase Of Business: -4500000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -10000000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Purchase Of PPE: -38500000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Raw Materials: 18200000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Raw Materials: 18200000.00
MEDX.SW income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 324200000.00
MEDX.SW income_statement (annual, 2024-12-31) — Reconciled Depreciation: 61600000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Repayment Of Debt: -37700000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -500000.00
MEDX.SW income_statement (annual, 2024-12-31) — Research And Development: 25400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Restricted Cash: 21900000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 21900000.00
MEDX.SW income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1800000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Retained Earnings: 498900000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 498900000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
MEDX.SW cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
MEDX.SW cash_flow (annual, 2024-12-31) — Sale Of PPE: 1500000.00
MEDX.SW income_statement (annual, 2024-12-31) — Selling General And Administration: 116400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Share Issued: 41262370.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Share Issued: 41262370.00
MEDX.SW cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 16400000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -37700000.00
MEDX.SW income_statement (annual, 2024-12-31) — Special Income Charges: -6200000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Stockholders Equity: 436400000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 436400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Tangible Book Value: 47600000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 47600000.00
MEDX.SW income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -76300.00
MEDX.SW income_statement (annual, 2024-12-31) — Tax Provision: 0.00
MEDX.SW income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
MEDX.SW balance_sheet (annual, 2024-12-31) — Taxes Receivable: 5100000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 5100000.00
MEDX.SW cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -9600000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Assets: 954200000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Assets: 954200000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Capitalization: 684600000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 684600000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Debt: 323400000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Debt: 323400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 446700000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 446700000.00
MEDX.SW income_statement (annual, 2024-12-31) — Total Expenses: 465800000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 507500000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 507500000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 693000000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 693000000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 344600000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 344600000.00
MEDX.SW income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 12900000.00
MEDX.SW income_statement (annual, 2024-12-31) — Total Other Finance Cost: 800000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Total Tax Payable: 15500000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 15500000.00
MEDX.SW income_statement (annual, 2024-12-31) — Total Unusual Items: -10900000.00
MEDX.SW income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -10900000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 471618.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 471618.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Treasury Stock: 14500000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 14500000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Work In Process: 22400000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Work In Process: 22400000.00
MEDX.SW balance_sheet (annual, 2024-12-31) — Working Capital: 98300000.00
MEDX.SW balance_sheet (quarterly, 2024-12-31) — Working Capital: 98300000.00
MEDX.SW income_statement (annual, 2024-12-31) — Write Off: 0.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 48200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 51300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 71300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Capital Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 100100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 108400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Common Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 424000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Assets: 268300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 9600000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Debt: 500000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 10100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 171200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Current Provisions: 14900000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 26200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 24700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Goodwill: 267300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 376000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Gross PPE: 264100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Inventory: 79200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Invested Capital: 673200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 0.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 0.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 61700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 248700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 310400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 0.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Minority Interest: 6400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Net Debt: 149100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Net PPE: 264100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 48000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 17700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 16400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 2100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40819385.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2600000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 108700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 19100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Payable: 10300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Properties: 264100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Receivables: 23500000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 8300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Payables: 109500000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4100000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 3300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 489600000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 41262370.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 424000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 48000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 2500000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 952600000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 672700000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Debt: 320500000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 430400000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 522200000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 684300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 351000000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 26300000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 442985.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 11900000.00
MEDX.SW balance_sheet (quarterly, 2025-06-30) — Working Capital: 97100000.00
MEDX.SW income_statement (annual, 2025-12-31) — +Operating Expense: 134100000.00
MEDX.SW income_statement (annual, 2025-12-31) — +Total Revenue: 448000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Accounts Payable: 43000000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 43000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Accounts Receivable: 50300000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 50300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -204200000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -204200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
MEDX.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 40773826.00
MEDX.SW income_statement (annual, 2025-12-31) — Basic EPS: 0.16
MEDX.SW cash_flow (annual, 2025-12-31) — Beginning Cash Position: 118100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 53600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 53600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Capital Expenditure: -41100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 72100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 72100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 400000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 82100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 82100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 90500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 90500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -15000000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Inventory: -2600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 7500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Payable: 5700000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -100000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Receivables: -12200000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Change In Working Capital: 1300000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Changes In Cash: -9200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Common Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 400000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 425700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 425700000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Common Stock Payments: -2600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Construction In Progress: 31400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 31400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Cost Of Revenue: 286100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Assets: 265300000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Assets: 265300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 10500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 10500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Debt: 9100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Debt: 9100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 19600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 19600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Liabilities: 171900000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 171900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Current Provisions: 16600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Current Provisions: 16600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Deferred Tax: 1900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 32200000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 32200000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Depreciation: 55500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 55500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 18400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 18400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 41511901.00
MEDX.SW income_statement (annual, 2025-12-31) — Diluted EPS: 0.15
MEDX.SW income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 6400000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Dividends Payable: 21700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 21700000.00
MEDX.SW income_statement (annual, 2025-12-31) — EBIT: 19700000.00
MEDX.SW income_statement (annual, 2025-12-31) — EBITDA: 75200000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -3400000.00
MEDX.SW cash_flow (annual, 2025-12-31) — End Cash Position: 105500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: -36300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Finished Goods: 35600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Finished Goods: 35600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: 26700000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -200000.00
MEDX.SW income_statement (annual, 2025-12-31) — General And Administrative Expense: 114900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Goodwill: 266500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Goodwill: 266500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 369800000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 369800000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 51600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 51600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Gross PPE: 473200000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Gross PPE: 473200000.00
MEDX.SW income_statement (annual, 2025-12-31) — Gross Profit: 161900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 500000.00
MEDX.SW income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 3100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Interest Expense: 10700000.00
MEDX.SW income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 10700000.00
MEDX.SW income_statement (annual, 2025-12-31) — Interest Income: 1400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1400000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -13800000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Inventory: 74200000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Inventory: 74200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 683900000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 683900000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: -40700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 0.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 0.00
MEDX.SW cash_flow (annual, 2025-12-31) — Issuance Of Debt: 23500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Land And Improvements: 95500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 95500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 61600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 61600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Long Term Debt: 249100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 249100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 310700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 310700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Long Term Provisions: 4700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 4700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 250000000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 250000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 7100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 7100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Minority Interests: -600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Net Debt: 176100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Net Debt: 176100000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 8200000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income: 6400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 6400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 7100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6400000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 7000000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 7100000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -6600000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Interest Income: -10600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -3200000.00
MEDX.SW income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -10600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Net PPE: 269000000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 269000000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -34100000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -3200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 55900000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 55900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 19500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 19500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 15700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 15700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Normalized EBITDA: 76200000.00
MEDX.SW income_statement (annual, 2025-12-31) — Normalized Income: 7184000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: 67800000.00
MEDX.SW income_statement (annual, 2025-12-31) — Operating Income: 27800000.00
MEDX.SW income_statement (annual, 2025-12-31) — Operating Revenue: 448000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 40672909.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 40672909.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Current Assets: 6600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 12600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 12600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Equity Interest: -100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 103300000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 103300000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: 10300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 200000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Properties: 42700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 42700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Receivables: 7600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 8400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 8400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Other Special Charges: -1100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Payables: 81800000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Payables: 81800000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1900000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 8700000.00
MEDX.SW income_statement (annual, 2025-12-31) — Pretax Income: 9000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Properties: 0.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MEDX.SW cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
MEDX.SW cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -6600000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Purchase Of PPE: -34500000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Raw Materials: 18000000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Raw Materials: 18000000.00
MEDX.SW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 286100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 55500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -26700000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2600000.00
MEDX.SW income_statement (annual, 2025-12-31) — Research And Development: 19600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Restricted Cash: 23400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 23400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 3000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: 495800000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 495800000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Sale Of PPE: 400000.00
MEDX.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 114900000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Share Issued: 41262370.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 41262370.00
MEDX.SW cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 23500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -26700000.00
MEDX.SW income_statement (annual, 2025-12-31) — Special Income Charges: -5000000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3100000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 425700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 425700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 55900000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 55900000.00
MEDX.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -216000.00
MEDX.SW income_statement (annual, 2025-12-31) — Tax Provision: 1900000.00
MEDX.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
MEDX.SW balance_sheet (annual, 2025-12-31) — Taxes Receivable: 3500000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 3500000.00
MEDX.SW cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -6700000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Assets: 956400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 956400000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 674800000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 674800000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Debt: 330300000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 330300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 432800000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 432800000.00
MEDX.SW income_statement (annual, 2025-12-31) — Total Expenses: 420200000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 523600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 523600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 691000000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 691000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 351700000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 351700000.00
MEDX.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 22800000.00
MEDX.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1300000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 17100000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 17100000.00
MEDX.SW income_statement (annual, 2025-12-31) — Total Unusual Items: -1000000.00
MEDX.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1000000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 589461.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 589461.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 13400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 13400000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Work In Process: 20600000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Work In Process: 20600000.00
MEDX.SW balance_sheet (annual, 2025-12-31) — Working Capital: 93400000.00
MEDX.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: 93400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 50300000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 58400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Capital Lease Obligations: 69000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Capital Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 102800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 111300000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Common Stock: 400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Common Stock Equity: 425000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Assets: 287900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Capital Lease Obligation: 10800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Debt: 800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Debt And Capital Lease Obligation: 11600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Liabilities: 188900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Current Provisions: 24000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Defined Pension Benefit: 34900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Derivative Product Liabilities: 18600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Dividends Payable: 23400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Goodwill: 266500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Goodwill And Other Intangible Assets: 364000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Gross PPE: 260900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Inventory: 81700000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Invested Capital: 675400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Investmentin Financial Assets: 0.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Long Term Capital Lease Obligation: 58200000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Long Term Debt: 249600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Long Term Debt And Capital Lease Obligation: 307800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Long Term Provisions: 4900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Minority Interest: 7800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Net Debt: 147600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Net PPE: 260900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Net Tangible Assets: 61000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Assets: 22500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Liabilities: 15300000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 2100000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Ordinary Shares Number: 40672909.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Current Assets: -200000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Current Liabilities: 24400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Intangible Assets: 97500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Non Current Assets: -100000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Non Current Liabilities: 100000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Properties: 260900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Receivables: 32900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Other Short Term Investments: 8500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Payables: 95600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Prepaid Assets: 1800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Retained Earnings: 494000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Share Issued: 40672909.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: 425000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: 61000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Taxes Receivable: 2000000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Assets: 970500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 674600000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Debt: 319400000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: 432800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 537700000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Non Current Assets: 682500000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Non Current Liabilities Net Minority Interest: 348800000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Total Tax Payable: 21900000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Treasury Stock: 12200000.00
MEDX.SW balance_sheet (quarterly, 2026-06-30) — Working Capital: 99000000.00
MEESHO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 75546240000.00
MEESHO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 57345190000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 8342020000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 3960000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -296120000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 77859830000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -345800000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Amortization: 54290000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 54290000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 5750000000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 4513131000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Basic EPS: -3.70
MEESHO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 4236780000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 221980000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -379970000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 116880000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 965460000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 21628930000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 965460000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 1708770000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -2846190000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Change In Payable: -4897390000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -273300000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -6308110000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -18216170000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 24719150000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 26394640000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 116880000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 116880000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 13699380000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Depreciation: 246070000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 300360000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 300360000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 246070000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 4513131000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Diluted EPS: -3.70
MEESHO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — EBIT: -16705630000.00
MEESHO.NS income_statement (annual, 2023-03-31) — EBITDA: -16405270000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 162870000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 965460000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -118070000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -23461880000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -628890000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 22460000.00
MEESHO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 2715620000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 236780000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 349760000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 637590000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 2950620000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 1310000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Interest Expense: 13390000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 13390000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Interest Income: 963170000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 963170000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -13390000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 874860000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 24719150000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 4983810000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 8700620000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 415610000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -16719020000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -16719020000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 829460000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 4473890000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 829460000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 341470000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -364940000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 24482370000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 114960000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 2493130000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: -17018180000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Normalized Income: -17331930000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -23081910000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Operating Income: -18201050000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 57345190000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 4513131000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 14781980000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 7091810000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 236780000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -977300000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 39660000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 6801870000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 5025960000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1486620000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 20663470000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Payables: 13367980000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 214520000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Preferred Stock: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 2722130000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Pretax Income: -16719020000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 250810000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -147847750000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -379970000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 300360000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 13200000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 13200000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 553000000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -59468500000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 152321640000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 15030000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 57445870000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 60161490000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 4513131000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Special Income Charges: -15980000.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 1060000000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 24719150000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 24482370000.00
MEESHO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
MEESHO.NS income_statement (annual, 2023-03-31) — Tax Provision: 0.00
MEESHO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
MEESHO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -98200000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 38533490000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 24719150000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 116880000.00
MEESHO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 24719150000.00